Instrumento Inactivo

Acciones Immunosyn Corp

Acciones

Precio de cierre Other OTC Otros sitios de cotización
- ^USD	-

IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	16/07/08
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	17/05/08
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	31/03/08
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	26/02/08
Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	01/02/08

Directores	Puesto	Edad	Desde
Stephen D. Ferrone CEO	Chief Executive Officer	73	15/10/07
Douglas A. McClain DFI	Director of Finance/CFO	49	-

Administradores	Puesto	Edad	Desde
Douglas A. McClain DFI	Director of Finance/CFO	49	-
Stephen D. Ferrone CEO	Chief Executive Officer	73	15/10/07

Sector

	Varia. 1 de ene.	Capi.
CSL LIMITED	+1,89 %	94 mil M
SAMSUNG BIOLOGICS CO.,LTD.	-0,13 %	39,05 mil M
BIOGEN INC.	-10,43 %	33,74 mil M
UCB	+78,64 %	28,54 mil M
BIOMARIN PHARMACEUTICAL INC.	-14,82 %	15,59 mil M
INCYTE CORPORATION	-3,06 %	13,69 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12,76 %	11,44 mil M
ALTEOGEN INC.	+181,73 %	10,66 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-53,92 %	9274,4 M